Luligard 1% Cream contains luliconazole, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin. Luliconazole belongs to the imidazole class of antifungals and exhibits broad-spectrum activity against dermatophytes, yeasts, and molds by inhibiting the biosynthesis of ergosterol, an essential component of fungal cell membranes. This disruption results in increased membrane permeability and ultimately fungal cell death. Luligard 1% Cream is primarily used for the management of conditions such as tinea corporis, tinea cruris, and tinea pedis. The cream formulation allows for effective penetration into the stratum corneum, providing targeted antifungal action with minimal systemic absorption. It is typically applied once daily to the affected area and surrounding skin for a duration determined by the severity and type of infection, usually ranging from one to two weeks. Common adverse effects are generally mild and may include local irritation, burning, or erythema at the application site. Luligard 1% Cream is contraindicated in individuals with known hypersensitivity to luliconazole or any excipients in the formulation. As with all topical antifungals, adherence to the prescribed regimen is essential to ensure complete eradication of the infection and to prevent recurrence.